| abstract |
A modulator of an ATP binding cassette ("ABC") transporter and a method of treating an ABC transporter mediated disease using the same. The compounds of the present invention and pharmaceutically acceptable compositions thereof include an ATP binding cassette (“ABC”) transporter or fragment thereof comprising a cystic fibrosis transmembrane conductance regulator (“CFTR”). It is useful as a modulator. The present invention also relates to a method for treating ABC transporter mediated diseases using the compounds of the present invention. [Selection figure] None |